162 related articles for article (PubMed ID: 38630705)
21. Disease-associated mutations in IRF6 and RIPK4 dysregulate their signalling functions.
Kwa MQ; Huynh J; Reynolds EC; Hamilton JA; Scholz GM
Cell Signal; 2015 Jul; 27(7):1509-16. PubMed ID: 25784454
[TBL] [Abstract][Full Text] [Related]
22. Insight Into the Function of RIPK4 in Keratinocyte Differentiation and Carcinogenesis.
Xu J; Wei Q; He Z
Front Oncol; 2020; 10():1562. PubMed ID: 32923402
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA miR-330-3p suppresses the progression of ovarian cancer by targeting RIPK4.
Cai L; Ye L; Hu X; He W; Zhuang D; Guo Q; Shu K; Jie Y
Bioengineered; 2021 Dec; 12(1):440-449. PubMed ID: 33487072
[TBL] [Abstract][Full Text] [Related]
24. Keratin 14 is a novel interaction partner of keratinocyte differentiation regulator: receptor-interacting protein kinase 4.
Sümer C; Boz Er AB; Dinçer T
Turk J Biol; 2019; 43(4):225-234. PubMed ID: 31582880
[TBL] [Abstract][Full Text] [Related]
25. The RIPK4-IRF6 signalling axis safeguards epidermal differentiation and barrier function.
Oberbeck N; Pham VC; Webster JD; Reja R; Huang CS; Zhang Y; Roose-Girma M; Warming S; Li Q; Birnberg A; Wong W; Sandoval W; Kőműves LG; Yu K; Dugger DL; Maltzman A; Newton K; Dixit VM
Nature; 2019 Oct; 574(7777):249-253. PubMed ID: 31578523
[TBL] [Abstract][Full Text] [Related]
26. Silencing of RIPK4 inhibits epithelial‑mesenchymal transition by inactivating the Wnt/β‑catenin signaling pathway in osteosarcoma.
Yi Z; Pu Y; Gou R; Chen Y; Ren X; Liu W; Dong P
Mol Med Rep; 2020 Mar; 21(3):1154-1162. PubMed ID: 32016450
[TBL] [Abstract][Full Text] [Related]
27. Mutations in RIPK4 cause the autosomal-recessive form of popliteal pterygium syndrome.
Kalay E; Sezgin O; Chellappa V; Mutlu M; Morsy H; Kayserili H; Kreiger E; Cansu A; Toraman B; Abdalla EM; Aslan Y; Pillai S; Akarsu NA
Am J Hum Genet; 2012 Jan; 90(1):76-85. PubMed ID: 22197489
[TBL] [Abstract][Full Text] [Related]
28. LncRNA MIR31HG promotes cell proliferation and invasive properties of the MCF-7 cell line by regulation of receptor-interacting serine-threonine kinase 4.
Tang J; Zhang X; Chen C; Wang B; Chen Y; Zhang H; Qiao M; Liu X; Guo W; Jin G
Acta Biochim Pol; 2023 Dec; 70(4):935-941. PubMed ID: 38064252
[TBL] [Abstract][Full Text] [Related]
29. Phosphorylation of Pkp1 by RIPK4 regulates epidermal differentiation and skin tumorigenesis.
Lee P; Jiang S; Li Y; Yue J; Gou X; Chen SY; Zhao Y; Schober M; Tan M; Wu X
EMBO J; 2017 Jul; 36(13):1963-1980. PubMed ID: 28507225
[TBL] [Abstract][Full Text] [Related]
30. IKKalpha enhances human keratinocyte differentiation and determines the histological variant of epidermal squamous cell carcinomas.
Moreno-Maldonado R; Ramírez A; Navarro M; Fernández-Aceñero MJ; Villanueva C; Page A; Jorcano JL; Bravo A; Llanos Casanova M
Cell Cycle; 2008 Jul; 7(13):2021-9. PubMed ID: 18604171
[TBL] [Abstract][Full Text] [Related]
31. Notch1 is a p53 target gene involved in human keratinocyte tumor suppression through negative regulation of ROCK1/2 and MRCKalpha kinases.
Lefort K; Mandinova A; Ostano P; Kolev V; Calpini V; Kolfschoten I; Devgan V; Lieb J; Raffoul W; Hohl D; Neel V; Garlick J; Chiorino G; Dotto GP
Genes Dev; 2007 Mar; 21(5):562-77. PubMed ID: 17344417
[TBL] [Abstract][Full Text] [Related]
32. Lysophosphatidic acid inhibits adipocyte differentiation via lysophosphatidic acid 1 receptor-dependent down-regulation of peroxisome proliferator-activated receptor gamma2.
Simon MF; Daviaud D; Pradère JP; Grès S; Guigné C; Wabitsch M; Chun J; Valet P; Saulnier-Blache JS
J Biol Chem; 2005 Apr; 280(15):14656-62. PubMed ID: 15710620
[TBL] [Abstract][Full Text] [Related]
33. RIPK4 promotes bladder urothelial carcinoma cell aggressiveness by upregulating VEGF-A through the NF-κB pathway.
Liu JY; Zeng QH; Cao PG; Xie D; Chen X; Yang F; He LY; Dai YB; Li JJ; Liu XM; Zeng HL; Zhu YX; Gong L; Cheng Y; Zhou JD; Hu J; Bo H; Xu ZZ; Cao K
Br J Cancer; 2018 Jun; 118(12):1617-1627. PubMed ID: 29867225
[TBL] [Abstract][Full Text] [Related]
34. Lysophospholipids improve skin moisturization by modulating of calcium-dependent cell differentiation pathway.
Yahagi S; Koike M; Okano Y; Masaki H
Int J Cosmet Sci; 2011 Jun; 33(3):251-6. PubMed ID: 21272041
[TBL] [Abstract][Full Text] [Related]
35. Abnormal expression of retinoic acid receptors and keratin 19 by human oral and epidermal squamous cell carcinoma cell lines.
Hu L; Crowe DL; Rheinwald JG; Chambon P; Gudas LJ
Cancer Res; 1991 Aug; 51(15):3972-81. PubMed ID: 1713123
[TBL] [Abstract][Full Text] [Related]
36. Phosphorylation of Dishevelled by protein kinase RIPK4 regulates Wnt signaling.
Huang X; McGann JC; Liu BY; Hannoush RN; Lill JR; Pham V; Newton K; Kakunda M; Liu J; Yu C; Hymowitz SG; Hongo JA; Wynshaw-Boris A; Polakis P; Harland RM; Dixit VM
Science; 2013 Mar; 339(6126):1441-5. PubMed ID: 23371553
[TBL] [Abstract][Full Text] [Related]
37. Influence of protein kinase RIPK4 expression on the apoptosis and proliferation of chondrocytes in osteoarthritis.
Zou L; Liu J; Lu H
Mol Med Rep; 2018 Feb; 17(2):3078-3084. PubMed ID: 29257245
[TBL] [Abstract][Full Text] [Related]
38. RIPK4 Promotes Cell Invasion and the Epithelial-Mesenchymal Transition in Ovarian Cancer.
Hua L; Wu JH; Xu JY; Wu SG; Zhou J
Front Biosci (Landmark Ed); 2023 Dec; 28(12):368. PubMed ID: 38179758
[TBL] [Abstract][Full Text] [Related]
39. Lysophosphatidic acid interacts with transforming growth factor-beta signaling to mediate keratinocyte growth arrest and chemotaxis.
Sauer B; Vogler R; Zimmermann K; Fujii M; Anzano MB; Schäfer-Korting M; Roberts AB; Kleuser B
J Invest Dermatol; 2004 Nov; 123(5):840-9. PubMed ID: 15482469
[TBL] [Abstract][Full Text] [Related]
40. Downregulation of RIPK4 Expression Inhibits Epithelial-Mesenchymal Transition in Ovarian Cancer through IL-6.
Yi H; Su YZ; Lin R; Zheng XQ; Pan D; Lin DM; Gao X; Zhang R
J Immunol Res; 2021; 2021():8875450. PubMed ID: 33855091
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
